GDF9 anticorps (N-Term)
Aperçu rapide pour GDF9 anticorps (N-Term) (ABIN952487)
Antigène
Voir toutes GDF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 87-117, N-Term
-
Specificité
- This antibody recognizes Human GDF9 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 87-117 amino acids from the N-terminal region of Human GDF9
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- GDF9 (Growth Differentiation Factor 9 (GDF9))
-
Autre désignation
- GDF9
-
Sujet
- Growth factors synthesized by ovarian somatic cells directly affect oocyte growth and function. Growth differentiation factor-9 (GDF9) is expressed in oocytes and is thought to be required for ovarian folliculogenesis. GDF9 is a member of the transforming growth factor-beta superfamily.Synonyms: GDF-9, Growth/differentiation factor 9
-
Poids moléculaire
- 51444 Da
-
ID gène
- 2661
-
NCBI Accession
- NP_005251
Antigène
-